Case 1: Gvhd Background

Case 1: GvHD Background

Targeted Oncology

Case 1: Treating Acute Graft-Versus-Host Disease

Targeted Oncology

Case 1: Personal Approach to Treatment for Acute GVHD

Targeted Oncology

Case 1: A Patient With Acute Graft-Vs-Host Disease

Targeted Oncology

Case 1: Staging of Acute Graft-vs-Host Disease

Targeted Oncology

Mapping the future of Hemopoietic Cell Transplants: MAGIC Biomarkers

Icahn School of Medicine

Case Overview: 49-Year-Old Man With Chronic GvHD

Targeted Oncology

Initial, Steroid-Refractory, and Novel Treatment Options for GVHD

Targeted Oncology

Case 3: Moderate Chronic Graft-Versus-Host Disease

Targeted Oncology

Case study | Therapy-refractory chronic GvHD

GVHD in 2022: from prevention to therapy

International Academy for Clinical Hematology IACH

“Building a Graft vs. Host Disease Program at UH Seidman Cancer Center” by Molly Gallogly, MD, PhD

Case 2: Steroid-Refractory Acute Graft-Versus-Host Disease

Targeted Oncology

Post-transplant complications in women: unseen GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Chronic Graft versus Host Disease of Skin and Connective Tissues 2016

Overcoming the Challenges of Acute and Chronic GVHD

PeerView Oncology

Introduction to Graft-versus-Host Disease 2022

Graft-Versus-Host Disease/Graft-Versus-Leukemia: Recent Advances in Therapy

Henry Ford Health

Graft versus host disease (Radiopaedia.org) Cases in Radiology

Introduction to Chronic Graft-vs-Host Disease (GVHD) 2018